Speakers

Adam Taylor

Senior Scientist

DIST

Adrienne Wildt

Director - Analytical Development

ImmunoGen 

Alex Sabogal

Scientist II, Process Development

Bolt Biotherapeutics, Inc.

Alison Hannah

Chief Medical Officer

CytomX

Aman Singh

Senior Scientist

Johnson & Johnson

Amy Han

Director - Research & Development

Regeneron

Andrea Gonzalez-Munoz

Scientist & Research Associate

AstraZeneca

Andrew Polson

Principal Scientist

Genentech

Arturo Molina

Chief Medical Officer

Sutro Biopharma

Aubrey Morgart

Kadcyla Patient

Bert Thomas

Senior Vice President - Business Development

BioThera Solutions

Bill Olson

Senior Vice President, Therapeutic Proteins

Regeneron

BinQing Wei

Scientist

Genentech

Bob Liu

Senior Scientist

CytomX

Brian Clark

Principal Consultant

GMP Operations Consulting

Brian O’Mara

Associate Director - Downstream Process Development

Ambrx

Brian Safina

Vice President - Chemistry

Bolt Biotherapeutics

Chet Bohac

Senior Clinical Research Director

Macrogenics

Christian Rohlff

Chief Executive Officer

Oxford Biotherapeutis

Chunze Li

Associate Director, Group Leader & Principal Scientist - Clinical Pharmacology

Genentech

Daniel Milano

Senior Manager, DS/DP Development & Manufacturing

Immunogen

Danny Dong Jun Lee

Senior Scientist II

AbbVie

Dario Neri

Professor of Biomacromolecules at the Department of Chemistry and Applied Biosciences,

ETH Zürich & Co-founder, Philogen

David Conlon

Senior Director, CMC Management & Operations

Daiichi Sankyo

David Newman

Independent Consultant

Dina Hingorani

Organic Chemist

UCSD

Ed Ha

Founding Principal Scientist - Antibody Drug Conjugates

AngieX

Edit Tarcsa

Director, Research Fellow DMPK-BA

AbbVie

Eric Lacoste

ADC Team Leader

Sanofi

Gilles Gallant

Senior Vice President, Global Head, Oncology Development

Daiichi Sankyo

Gordon Rigg

Independent Consultant

Greg Thurber

Associate Professor

University of Michigan

Hillary Schuessler

Scientific Leader & Critical Quality Attributes

Glaxo Smith Kline

Jay Harper

Associate Director, Research Oncology

AstraZneca

Jia He

Analyst

Beacon Targeted Therapies

John Lambert

Independent Consultant

Attager Consulting

Joshua Hunter

Senior Scientist - Conjugation Process Development

Seattle Genetics

Julian Andreev

Senior Staff Scientist & Research Fellow

Regeneron

Leo Kirkovsky

Director - Clinical Assay Group

Pfizer

Liangyi Zhang

Associate Director - Chemistry, Manufacturing & Control Analytical

ADC Therapeutics

Louie Naumovski

Group Medical Director

AbbVie

Marc Damelin

Executive Director, Head of Biology

Mersana

Marcello Marelli

Senior Scientist

AstraZeneca

Ming-Tan Lai

Head of Research & Development

OBI Pharma

Mingchao Kang

Project Leader

Ambrx

Nancy Levin

Vice President - Development

Triphase

Nick Choong

Executive Director

Seattle Genetics

Nicola Stagg

Senior Scientist & Toxicologist

Genentech

Patrick Van Berkel

Senior Vice President - Resesarch & Development

ADC Therapeutics

Patrick Zweidler Mckay

Immunogen

Paul Santacroce

Senior Scientist, Early Stage Formulation Sciences

AstraZeneca

Peiying Zuo

Director, Pharmacometrics

Astellas

Phil Howard

Chief Scientific Officer

Spirogen

Pradeep Dhal

Senior Director - Research & Development

Sanofi

Prathap Kumar Mahalingaiah

Senior Scientist II, Investigative Toxicology and Pathology

AbbVie

Rakesh Dixit

President & Founder

BioNavigen

Rick Powers

Independent Consultant

Robert Herbst

Senior Director - Process Development & Engineering

Immunogen

Ronald Fleming

Executive Director, Oncology Clinical Development,

Daiichi Sankyo

Sally Ward

Professor - Molecular Immunology & Director - Translational Immunology

University of Southampton

Sean Smith

Senior Director, Chemistry

SilverbackTherapeutics

Shabbir Anik

Chief Technical Operations Officer

Sutro Biopharma

Shiang Gwee

Group & Team Leader – Formulation Development, Chemistry, Manufacturing & Control

MacroGenics

Suman Mukherjee

Director

Merck

Tim Lowinger

Chief Scientific Officer

Mersana

Torbjörn Gräslund

Professor in Medical Protein Technology

KTH Royal Institute of Technology

Trevor Hallam

Chief Scientific Officer

Sutro Biopharma

Ulf Grawunder

Chief Executive Officer & Founder

NBE Therapeutics

Victoria Wei

Associate Director, Global Regulatory Affairs

Johnson & Johnson

Wayne Widdison

Independent Consultant

Ying Buechler

Vice President - Development

Ambrx